Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Aug 2;4(8):e2120360.
doi: 10.1001/jamanetworkopen.2021.20360.

Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017

Affiliations
Comparative Study

Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017

Zhen Zhai et al. JAMA Netw Open. .

Abstract

Importance: It is difficult for policy makers and clinicians to formulate targeted management strategies for mesothelioma because data on current epidemiological patterns worldwide are lacking.

Objective: To evaluate the mesothelioma burden across the world and describe its epidemiological distribution over time and by sociodemographic index (SDI) level, geographic location, sex, and age.

Design, setting, and participants: Annual case data and age-standardized rates of incidence, death, and disability-adjusted life-years associated with mesothelioma among different age groups were obtained from the Global Burden of Disease 2017 database. The estimated annual percentage changes in age-standardized rates were calculated to evaluate temporal trends in incidence and mortality. The study population comprised individuals from 21 regions in 195 countries and territories who were diagnosed with mesothelioma between 1990 and 2017. Data were collected from May 23, 2019, to January 18, 2020.

Main outcomes and measures: Primary outcomes were incident cases, deaths, and their age-standardized rates and estimated annual percentage changes. Secondary outcomes were disability-adjusted life-years and relative temporal trends.

Results: Overall, 34 615 new cases (95% uncertainty interval [UI], 33 530-35 697 cases) of mesothelioma and 29 909 deaths (95% UI, 29 134-30 613 deaths) associated with mesothelioma were identified in 2017, and more than 70% of these cases and deaths were among male individuals. In 1990, the number of incident cases was 21 224 (95% UI, 17 503-25 450), and the number of deaths associated with mesothelioma was 17 406 (95% UI, 14 495-20 660). These numbers increased worldwide from 1990 to 2017, with more than 50% of cases recorded in regions with high SDI levels, whereas the age-standardized incidence rate (from 0.52 [95% UI, 0.43-0.62] in 1990 to 0.44 [95% UI, 0.42-0.45] in 2017) and the age-standardized death rate (from 0.44 [95% UI, 0.37-0.52] in 1990 to 0.38 [95% UI, 0.37-0.39] in 2017) decreased, with estimated annual percentage changes of -0.61 (95% CI, -0.67 to -0.54) for age-standardized incidence rate and -0.44 (95% CI, -0.52 to -0.37) for age-standardized death rate. The proportion of incident cases among those 70 years or older continued to increase (from 36.49% in 1990 to 44.67% in 2017), but the proportion of patients younger than 50 years decreased (from 16.74% in 1990 to 13.75% in 2017) over time. In addition, mesothelioma incident cases and age-standardized incidence rates began to decrease after 20 years of a complete ban on asbestos use. For example, in Italy, a complete ban on asbestos went into effect in 1992; incident cases increased from 1409 individuals (95% UI, 1013-1733 individuals) in 1990, peaked in 2015 after 23 years of the asbestos ban, then decreased from 1820 individuals (95% UI, 1699-1981 individuals) in 2015 to 1746 individuals (95% UI, 1555-1955 individuals) in 2017.

Conclusions and relevance: This cross-sectional study found that incident cases of mesothelioma and deaths associated with mesothelioma continuously increased worldwide, especially in resource-limited regions with low SDI levels. Based on these findings, global governments and medical institutions may consider formulating optimal policies and strategies for the targeted prevention and management of mesothelioma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Correlation of Estimated Annual Percentage Change (EAPC) in Mesothelioma Incidence, Deaths, and Disability-Adjusted Life-Years (DALYs) With Age-Standardized Rate of Mesothelioma in 1990 and Sociodemographic Index in 2017
The ρ indices and P values were derived using Pearson correlation analysis. Circles represent cases or deaths in countries and territories with available SDI data. Larger circles represent a greater number of cases or deaths. Incidence and deaths were calculated based on the number of mesothelioma cases per 200 people, and DALYs were calculated based on the number of mesothelioma cases per 4000 people.
Figure 2.
Figure 2.. Temporal Trends in Mesothelioma Cases Among 47 Countries With Complete Asbestos Bans
The solid blue curve reflects the overall trend of incident cases.
Figure 3.
Figure 3.. Comparison of Incident Mesothelioma Cases by Age and Region in 1990 and 2017
A, Region 1 indicates high-income Asia Pacific; region 2, central Asia; region 3, East Asia; region 4, South Asia; region 5, Southeast Asia; region 6, Australasia; region 7, Caribbean; region 8, central Europe; region 9, eastern Europe; region 10, western Europe; region 11, Andean Latin America. B, Region 12 indicates central Latin America; region 13, southern Latin America; region 14, tropical Latin America; region 15, North Africa and the Middle East; region 16, high-income North America; region 17, Oceania; region 18, central sub-Saharan Africa; region 19, eastern sub-Saharan Africa; region 20, southern sub-Saharan Africa; and region 21, western sub-Saharan Africa. Data from specific regions (central Asia, Caribbean, Andean Latin America, Oceania, and central sub-Saharan Africa) can be viewed in the top right of panel B.
Figure 4.
Figure 4.. Epidemiological Patterns of Mesothelioma Incidence in 195 Countries and Territories
Countries with a large number of cases or a large change in the number of cases were annotated. ASIR indicates age-standardized incidence rates.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492 - DOI - PubMed
    1. Jiang Z, Chen T, Chen J, et al. . Hand-spinning chrysotile exposure and risk of malignant mesothelioma: a case-control study in southeastern China. Int J Cancer. 2018;142(3):514-523. doi:10.1002/ijc.31077 - DOI - PubMed
    1. Mazurek JM, Syamlal G, Wood JM, Hendricks SA, Weston A. Malignant mesothelioma mortality—United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2017;66(8):214-218. doi:10.15585/mmwr.mm6608a3 - DOI - PMC - PubMed
    1. Mensi C, Giacomini S, Sieno C, Consonni D, Riboldi L. Pericardial mesothelioma and asbestos exposure. Int J Hyg Environ Health. 2011;214(3):276-279. doi:10.1016/j.ijheh.2010.11.005 - DOI - PubMed
    1. Kharazmi E, Chen T, Fallah M, et al. . Familial risk of pleural mesothelioma increased drastically in certain occupations: a nationwide prospective cohort study. Eur J Cancer. 2018;103:1-6. doi:10.1016/j.ejca.2018.07.139 - DOI - PubMed

Publication types